Moxibustion Reduces Symptoms and Improves Quality of Life in Patients With Allergic Rhinitis

Henan University of Traditional Chinese Medicine

Status: Enrolling

Conditions: Allergic Rhinitis

Treatments: Behavioral: First group of heavy moxibustion; Behavioral: Ordinary moxibustion volume group; Behavioral: Second groups of heavy moxibustion

Study type: Interventional

Funder types: Other

Identifiers

NCT06173882

TCM for AR

Details and patient eligibility

About

The objective of this randomized controlled clinical trial is to compare the therapeutic effect of moxibustion on allergic rhinitis. The main questions it aims to answer are:

Based on randomized controlled trials, verify the effectiveness of moxibustion in treating allergic rhinitis Based on a real-time monitoring system for human surface temperature, discuss the differences in therapeutic effects of different moxibustion doses on allergic rhinitis

Full description

Allergic rhinitis has a high incidence and is difficult to cure, seriously affecting the quality of life of patients Compare the effects of different moxibustion durations on the clinical efficacy and body surface temperature of patients with allergic rhinitis, and preliminarily explore the impact of different moxibustion doses on the efficacy of heavy moxibustion treatment for allergic rhinitis, providing evidence-based basis for clinical practice.

Enrollment: 90 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

• Those who meet the diagnostic criteria of Chinese and Western medicine for AR;
• Age range from 18 to 75 years old, regardless of gender;
• Patients and their families are informed and agree to the study.

Exclusion criteria

• Those who are undergoing other traditional Chinese medicine external treatment methods;
• Those who have taken traditional Chinese medicine recently or during treatment;
• Individuals who are allergic to heavy moxibustion smoke and dust;
• Individuals with concomitant bronchial asthma or other respiratory system diseases;
• Patients with severe skin diseases or ulcers in the local area where moxibustion is applied;
• Pregnant and lactating patients;
• Patients with severe diseases of important organs such as the heart, liver, lungs, and kidneys;
• Those who are unable to receive treatment according to regulations due to inconvenience in work, study, transportation, or personal activities

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

90 participants in 3 patient groups, including a placebo group

Ordinary moxibustion volume group

Placebo Comparator group

Treatment:

Behavioral: Ordinary moxibustion volume group

First group of heavy moxibustion

Experimental group

Treatment:

Behavioral: First group of heavy moxibustion

Second groups of heavy moxibustion

Experimental group

Treatment:

Behavioral: Second groups of heavy moxibustion